On February 2, 2026, Legend Biotech Corp appointed Gareth Kung to its Board of Directors, effective immediately, replacing Tomas Heyman as chair of the Audit Committee. Mr. Kung will receive a restricted share unit award worth $270,000 and an annual cash retainer of $75,000 for his service.